연구성과로 돌아가기
2025 연구성과별 연구자 정보 (768 / 1187)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase change-induced heterointerface engineering of hollow sphere structured graphene oxide/layered double hydroxide composites for superior pseudocapacitive energy storage in lithium-ion batteries | Paek, Seung-Min | Paek, SM | 4 | 교신저자 | Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea | E-4667-2011 | Paek, Seung-Min | 0000-0003-4923-2809 | Paek, Seung-Min | jaemin.oh@dongguk.edu; smpaek@knu.ac.kr; |
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Sohn, Joohyuk | Sohn, J | 1 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Lim, Seungtaek | Lim, S | 2 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Jeong, Jae Ho | Jeong, JH | 3 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Lee, Kyung-Hun | Lee, KH | 4 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Lee, Keun Seok | Lee, KS | 5 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Moon, Yong Wha | Moon, YW | 6 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Kim, Ji-Yeon | Kim, JY | 7 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Lee, Jieun | Lee, J | 8 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Kim, Hee Jun | Kim, HJ | 9 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Chae, Yee Soo | Chae, YS | 10 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Kim, Jee Hung | Kim, JH | 11 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Lee, Suee | Lee, S | 12 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Park, In Hae | Park, IH | 13 | |||||||
| Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. | Kang, Seok Yun | Kang, SY | 14 |
페이지 이동: